Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Since 2015, EAPC has recognised outstanding research achievement with the presentation of the Viviane Conraads Award at EuroPrevent.
Professor Paul Dendale, EAPC President, described the background to the award: “Doctor Viviane Conraads was a leading figure in the EAPC—she played a very important role as a nucleus member of the Exercise, Basic and Translational Research Section and as a Congress Programme Committee member. Notably, she also actively encouraged young investigators in their work on cardiac prevention and rehabilitation. Viviane sadly died prematurely, and an award in her name was established to honour her memory and the spirit by which she promoted young researchers to become established researchers.”
Applications for the Viviane Conraads Award are open to EAPC members aged less than 45 years who have sustained outstanding productivity over several years, resulting in a significant contribution to their chosen field.
Prof. Dendale continued, “This year, we have chosen Professor Emanuele Di Angelantonio as the winner of the Viviane Conraads Award. Prof. Di Angelantonio is using epidemiology as a very effective tool to improve prevention of cardiovascular (CV) disease (CVD)—he has already published many important studies and made a significant contribution to the work of our association as a nucleus member of the Population Science and Public Health Section. We take great pleasure in presenting him with this well-deserved award.”
Prof. Di Angelantonio trained as a physician in internal medicine and CV medicine in Italy and France. He then moved to the UK, gaining a MSc in medical statistics at the London School of Hygiene and Tropical Medicine in 2005 and a PhD in epidemiology at the University of Cambridge in 2009. Prof. Di Angelantonio currently works at the Department of Public Health and Primary Care, University of Cambridge. A key approach of his work is the systematic and detailed analyses of large-scale prospective epidemiological data, which have sought to address several longstanding controversies in relation to CV risk factors and prediction. For example, he has demonstrated that lipid assessment can be greatly simplified by measurement of total cholesterol and high-density lipoprotein-cholesterol without the need to fast and without regard to triglyceride levels, which has implications for millions of adults screened by health services.
He has strengthened the epidemiological basis of diabetes prevention programmes by demonstrating that diabetes and dysglycaemia are independently associated with premature death from a range of vascular and non-vascular conditions and that people aged 60 years with cardiometabolic multimorbidity live about 15 years less than counterparts without cardiometabolic multimorbidity.
Prof. Di Angelantonio has also shown that, in contrast with previous suggestions, general adiposity and central adiposity are similarly important to CV risk, but that they add little incremental value to risk prediction in developed countries when additional information is available for systolic blood pressure, history of diabetes and lipids. Furthermore, in a study of around 10 million participants across 32 countries, he has shown that overweight and obesity are unequivocally associated with higher mortality, challenging previous claims, and supporting guidelines to globally combat the entire spectrum of excess adiposity.
With these findings and his other research, Prof. Di Angelantonio has engaged extensively with various organisations to help shape CVD risk management guidelines and his work on risk factors and risk prediction strategies has heavily influenced risk management.
Prof. Di Angelantonio said, “I am really honoured to win the Viviane Conraads Award. It is a great way to be able to highlight my research and that of my group, and I thank the Board for the opportunity to be able to address delegates at EuroPrevent 2019.”
Special event: Hear Prof. Di Angelantonio speak about his work at the EuroPrevent 2019 Closing Ceremony
Saturday: 12:15 – 13:00; Porto
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved